Skip to main content
SpringerLink
Log in

Pharmacotherapy in Women

  • Chapter
  • First Online:
Manual of Gynecardiology

  • 414 Accesses

Abstract

Pharmacokinetic properties such as absorption, distribution, metabolism, and elimination of drugs often differ between men and women and change over lifetime. Women experience more adverse events and side-effects of medications than men. Hormonal changes during the menstrual cycle usually have limited effect on the pharmacokinetics of drugs, except for drugs that interfere with QT-interval. It is debated whether there is a systematic difference in compliance to medication in women compared to men. Drug interactions and drug safety during pregnancy are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Socialstyrelsen. Statistik om läkemedel år 2015 (Drug Statistics, Swedish Board of Health and Welfare). http://www.socialstyrelsen.se/publikationer2016/2016-4-4. Accessed 31 Jul 2016.

  2. Loikas D, Wettermark B, von Euler M, Bergman U, Schenck-Gustafsson K. Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden. BMJ Open. 2013;3(5):e002378.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Mattison D, Mattison FA. Drug disposition and effect. In: Handbook of clinical gender medicine. Basel: Karger Medical and Scientific Publishers; 2012. p. 473–9.

    Chapter  Google Scholar 

  4. Koren G. Sex dependent pharmacokinetics and bioequivalence—time for a change. J Popul Ther Clin Pharmacol. 2013;20:e358–61.

    PubMed  Google Scholar 

  5. Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol. 2008;83:1–10.

    Article  PubMed  Google Scholar 

  6. Anderson GD. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Women’s Health. 2005;14:19–29.

    Article  Google Scholar 

  7. Franconi F, Campesi I. Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women. Br J Pharmacol. 2014;171:580–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res. 2002;53:672–7.

    Article  CAS  PubMed  Google Scholar 

  9. Hutson WR, Roehrkasse RL, Wald A. Influence of gender and menopause on gastric emptying and motility. Gastroenterology. 1989;96:11–7.

    Article  CAS  PubMed  Google Scholar 

  10. Mearadji B, Penning C, Vu MK, van der Schaar PJ, van Petersen AS, Kamerling IM, Masclee AA. Influence of gender on proximal gastric motor and sensory function. Am J Gastroenterol. 2001;96:2066–73.

    Article  CAS  PubMed  Google Scholar 

  11. Sadik R, Abrahamsson H, Stotzer PO. Gender differences in gut transit shown with a newly developed radiological procedure. Scand J Gastroenterol. 2003;38:36–42.

    Article  CAS  PubMed  Google Scholar 

  12. Schwartz JB. The influence of sex on pharmacokinetics. Clin Pharmacokinet. 2003;42:107–21.

    Article  CAS  PubMed  Google Scholar 

  13. Singer AJ, Brandt LJ. Pathophysiology of the gastrointestinal tract during pregnancy. Am J Gastroenterol. 1991;86:1695–712.

    CAS  PubMed  Google Scholar 

  14. Spoletini I, Vitale C, Malorni WMC, Rosano GM. Sex differences in drug effects: interaction with sex hormones in adult life. Sex and gender differences in pharmacology. In: Regitz-Zagrosek W, editor. Handbook of experimental pharmacology, vol. 214. Berlin: Springer; 2012. p. 91–105.

    Google Scholar 

  15. Rodriguez I, Kilborn MJ, Liu XK, Pezzullo JC, Woosley RL. Drug-induced QT prolongation in women during the menstrual cycle. JAMA. 2001;285:1322–6.

    Article  CAS  PubMed  Google Scholar 

  16. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–5.

    Article  CAS  PubMed  Google Scholar 

  17. von Euler M, Eliasson E, Öhlén G, Bergman U. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf. 2006;15:179–84.

    Article  Google Scholar 

  18. Leise MD, Poterucha JJ, Talwalkar JA. Drug-induced liver injury. Mayo Clin Proc. 2014;89:95–106.

    Article  CAS  PubMed  Google Scholar 

  19. Amacher DE. Female gender as a susceptibility factor for drug-induced liver injury. Hum Exp Toxicol. 2014;33:928–39.

    Article  PubMed  Google Scholar 

  20. Melloni C, Berger JS, Wang TY, Gunes F, Stebbins A, Pieper KS, Dolor RJ, Douglas PS, Mark DB, Newby LK. Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ Cardiovasc Qual Outcomes. 2010;3:135–42.

    Article  PubMed  Google Scholar 

  21. Eriksson I, Bergman U, Vlahovic-Palcevski V, von Euler M. Drug utilization studies across patient and prescriber characteristics. In: Elseviers M, Wettermark B, Birna Almarsdóttir A, Andersen M, Benko R, Bennie M, Eriksson I, Godman B, Krska J, Poluzzi E, Taxis K, Vlahovic-Palcevski V, Vander Stichele R, editors. Drug utilization research: methods and applications. Hoboken: Wiley; 2016.

    Google Scholar 

  22. Stephen M, Wiggins HS, Englyst HN. The effect of age, sex and level of intake of dietary fibre from wheat on large-bowel function in thirty healthy subjects. Br J Nutr. 1986;56:349–61.

    Article  CAS  PubMed  Google Scholar 

  23. Goodman DE, Israel E, Rosenberg M, Johnston R, Weiss ST, Drazen JM. The influence of age, diagnosis, and gender on proper use of metered-dose inhalers. Am J Respir Crit Care Med. 1994;150:1256–61.

    Article  CAS  PubMed  Google Scholar 

  24. Atkinson AJ, Anernathy DR, Daniels CE, Dedrick RL, Markey SP, editors. Principles of clinical pharmacology. 2nd ed. San Diego: Academic/Elsevier; 2007.

    Google Scholar 

  25. Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber CS. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med. 1990;322:95–9.

    Article  CAS  PubMed  Google Scholar 

  26. SBU. Skattning av njurfunktion: en systematisk litteraturöversikt. Rapport nr: 214. Mölnlycke: Elanders; 2013. ISBN: 978-91-85413-53-9.

    Google Scholar 

  27. Skoglund P. Farmakokinetiska grundbegrepp. Apoteket AB. Marknads-/Försäljningsstöd; 2001.

    Google Scholar 

  28. Pieper PG. Use of medication for cardiovascular disease during pregnancy. Nat Rev Cardiol. 2015;12:718–29.

    Article  CAS  PubMed  Google Scholar 

  29. Mitoff PR, Gam D, Ivanov J, Al-hesayen A, Azevedo ER, Newton GE, Parker JD, Mak S. Cardiac-specific sympathetic activation in men and women with and without heart failure. Heart. 2011;97:382–7.

    Article  PubMed  Google Scholar 

  30. Momen A, Gao Z, Cohen A, Khan T, Leuenberger UA, Sinoway LI. Coronary vasoconstrictor responses are attenuated in young women as compared with age-matched men. J Physiol. 2010;588:4007–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kneale BJ, Chowienczyk PJ, Brett SE, Coltart DJ, Ritter JM. Gender differences in sensitivity to adrenergic agonists of forearm resistance vasculature. J Am Coll Cardiol. 2000;36:1233.

    Article  CAS  PubMed  Google Scholar 

  32. Wheeldon NM, Newnham DM, Coutie WJ, Peters JA, McDevitt DG, Lipworth BJ. Influence of sex-steroid hormones on the regulation of lymphocyte beta 2-adrenoceptors during the menstrual cycle. Br J Clin Pharmacol. 1994;37:583–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Kam KW, Qi JS, Chen M, Wong TM. Estrogen reduces cardiac injury and expression of beta1-adrenoceptor upon ischemic insult in the rat heart. J Pharmacol Exp Ther. 2004;309:8–15.

    Article  CAS  PubMed  Google Scholar 

  34. Thawornkaiwong A, Preawnim S, Wattanapermpool J. Upregulation of β1-adrenergic receptors in ovariectomized rat hearts. Life Sci. 2003;72:1813–24.

    Article  CAS  PubMed  Google Scholar 

  35. Kotecha D, Manzano L, Krum H, et al. Effect of age and sex on efficacy and tolerability of β-blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis. BMJ. 2016;353:i18.

    Google Scholar 

  36. Weinberger AH, McKee SA, Mazure CM. Inclusion of women and gender-specific analyses in randomized clinical trials of treatments for depression. J Womens Health (Larchmt). 2010;19:1727–32.

    Article  Google Scholar 

  37. Tannenbaum C, Schwarz JM, Clayton JA, de Vries GJ, Sullivan C. Evaluating sex as a biological variable in preclinical research: the devil in the details. Biol Sex Differ. 2016;7:13. doi:10.1186/s13293-016-0066-x.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Ward KE, Archambault R, Mersfelder TL. Severe adverse skin reactions to nonsteroidal anti-inflammatory drugs: a review of the literature. Am J Health Syst Pharm. 2010;67:206–13.

    Article  CAS  PubMed  Google Scholar 

  39. Willis CM, Shaw S, De Lacharrière O, Baverel M, Reiche L, Jourdain R, Bastien P, Wilkinson JD. Sensitive skin: an epidemiological study. Br J Dermatol. 2001;145:258–63.

    Article  CAS  PubMed  Google Scholar 

  40. Moss AJ. The QT interval and Torsade de pointes. Drug Saf. 1999;21(Suppl. 1):5–10.

    Article  CAS  PubMed  Google Scholar 

  41. Taylor CJ, Hodgkinson J, Hobbs FD. Rhythm control agents and adverse events in patients with atrial fibrillation. Int J Clin Pract. 2010;64:1069–75.

    Article  CAS  PubMed  Google Scholar 

  42. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013–22.

    Article  CAS  PubMed  Google Scholar 

  43. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for Torsades de pointes associated with cardiovascular drugs. JAMA. 1993;270:2590–7.

    Article  CAS  PubMed  Google Scholar 

  44. Fitzgerald PT, Ackerman MJ. Drug-induced torsades de pointes: the evolving role of pharmacogenetics. Heart Rhythm. 2005;2:S30–7.

    Article  PubMed  Google Scholar 

  45. Lehmann MH, Hardy S, Archibald D, MacNeil DJ. QTc prolongation with d,l-sotalol in women versus men. Am J Cardiol. 1999;83:354–9.

    Article  CAS  PubMed  Google Scholar 

  46. Schenck-Gustafsson K, Dahlqvist R. Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction. Br J Clin Pharmacol. 1981;11(2):181–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Reinoehl J, Frankovich D, Machado C, Kawasaki R, Baga JJ, Pires LA, et al. Probucol associated tachyarrhythmic events and QT prolongation: importance of gender. Am Heart J. 1996;131:1184–91.

    Article  CAS  PubMed  Google Scholar 

  48. Lim HE, Pak HN, Ahn JC, Song WH, Kim YH. Torsade de pointes induced by short-term oral amiodarone therapy. Europace. 2006;8:1051–3.

    Article  PubMed  Google Scholar 

  49. Os I, Bratland B, Dahlof B, Gisholt K, Syvertsen JO, Tretli S. Female sex as an important determinant of lisinopril-induced cough. Lancet. 1992;339:372.

    Article  CAS  PubMed  Google Scholar 

  50. Pasternak RC, Smith Jr SC, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. Circulation. 2002;106:1024–8.

    Article  PubMed  Google Scholar 

  51. Hou Q, Li S, Li L, Li Y, Sun X, Tian H. Association between SLCO1B1 gene T521C, polymorphism and statin-related myopathy risk: a meta-analysis of case-control studies. Medicine (Baltimore). 2015;94(37):e1268.

    Article  CAS  Google Scholar 

  52. Luzum JA, Kitzmiller JP, Isackson PJ, Ma C, Medina MW, Dauki AM, et al. GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals. Cell Metab. 2015;21:622–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Rosano GM, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, et al. Gender differences in the effect of cardiovascular drugs: a position document of the working group on pharmacology and drug therapy of the ESC. Eur Heart J. 2015;36:2677–80.

    Article  PubMed  Google Scholar 

  54. Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013;4:1–16.

    Article  Google Scholar 

  55. DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–9.

    Article  PubMed  Google Scholar 

  56. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart J-M, Gibbs JSR, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby MC, Maas AHEM, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L. ESC guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J. 2011;32:3147–97.

    Article  PubMed  Google Scholar 

  57. Lupattelli A, Spigset O, Björnsdóttir I, Hämeen-Anttila K, Mårdby AC, Panchaud A, Juraski RG, Rudolf G, Odalovic M, Drozd M, Twigg MJ, Juch H, Moretti ME, Kennedy D, Rieutord A, Zagorodnikova K, Passier A, Nordeng H. Patterns and factors associated with low adherence to psychotropic medications during pregnancy—a cross-sectional, multinational web-based study. Depress Anxiety. 2015;32:426–36.

    Article  PubMed  Google Scholar 

  58. www.janusinfo.se/In-English.

  59. https://crediblemeds.org/.

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Cardiac Unit, Center of Gender Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

    Karin Schenck-Gustafsson

  2. Karolinska Institutet Stroke Research Network, Södersjukhuset, Stockholm, Sweden

    Mia von Euler

  3. Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden

    Mia von Euler

  4. Department of Clinical Pharmacology, Karolinska University Hospital, Stockholm, Sweden

    Mia von Euler

Authors
  1. Karin Schenck-Gustafsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mia von Euler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karin Schenck-Gustafsson .

Editor information

Editors and Affiliations

  1. Department of Cardiology, Women’s Cardiac Health Program, Radboud University Medical Center, Nijmegen, The Netherlands

    Angela H.E.M. Maas

  2. Director Barbra Streisand Women’s Heart Center, Linda Joy Pollin Women’s Heart Health Program, Director Preventive Cardiac Center, Cedars-Sinai, Los Angeles, USA

    C. Noel Bairey Merz

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Schenck-Gustafsson, K., von Euler, M. (2017). Pharmacotherapy in Women. In: Maas, A., Bairey Merz, C. (eds) Manual of Gynecardiology. Springer, Cham. https://doi.org/10.1007/978-3-319-54960-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-54960-6_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-54959-0

  • Online ISBN: 978-3-319-54960-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation